Anaplastic giant‐cell carcinoma of the thyroid. A study of treatment and prognosis
In 79 cases of histologically verified anaplastic giant‐cell carcinoma, symptoms, treatment, and prognosis were documented. Seventy‐eight patients are dead, the mean survival time being 2.5 months. One patient is cured. It was concluded that surgery and/or radiotherapy alone are not sufficient. The...
Gespeichert in:
| Veröffentlicht in: | Cancer 1975-05, Vol.35 (5), p.1293-1295 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1295 |
|---|---|
| container_issue | 5 |
| container_start_page | 1293 |
| container_title | Cancer |
| container_volume | 35 |
| creator | Jereb, B. Stjernswärd, J. Löwhagen, T. |
| description | In 79 cases of histologically verified anaplastic giant‐cell carcinoma, symptoms, treatment, and prognosis were documented. Seventy‐eight patients are dead, the mean survival time being 2.5 months. One patient is cured. It was concluded that surgery and/or radiotherapy alone are not sufficient. The results from an additional 8 patients also treated with methotexate indicate a positive therapeutic effect, the mean survival time being 9.4 months. Disappearance of recurrent tumor or pulmonary metastases was noted in 2 patients. |
| doi_str_mv | 10.1002/1097-0142(197505)35:5<1293::AID-CNCR2820350504>3.0.CO;2-W |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_82789873</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>82789873</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2994-901977b15c2aac2076d9846e9f6075ff96b27f877e493cd77c0fa84ff3b51c73</originalsourceid><addsrcrecordid>eNpdkd9q2zAUh0VpabOuj1Dw1egunB1JViRlY2C8rg2EBkagvTsostS6-E9mOYzc7RH6jHuS2ktoaS-EkL6jI-n3EZJSGFMA9oWCljHQhF1QLQWIz1xMxTfKNJ9O09mPOLvJfjHFgPcMku98DONs8ZXFtwdk9HL2kIwAQMUi4Xcn5EMIj_1SMsGPyTGljCUKRmSZ1mZdmtAVNrovTN39-_tkXVlG1rS2qJvKRI2PugfXj23bFPk4SqPQbfLt__3Wma5ydReZOo_WbXNfN6EIH8mRN2VwZ_v5lCx_Xi6z63i-uJpl6TxeM62TWEP_O7miwjJjLAM5ybVKJk77CUjhvZ6smPRKSpdobnMpLXijEu_5SlAr-Sn5tGvbX_x740KHVRGGx5vaNZuAikmlleR94fm-cLOqXI7rtqhMu8V9Cj3Pd_xPUbrtKwYcbOCQKA6J4s4GcoECBxvYy8C3MpAjYLZAhrfvCH8GCGWETA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>82789873</pqid></control><display><type>article</type><title>Anaplastic giant‐cell carcinoma of the thyroid. A study of treatment and prognosis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Jereb, B. ; Stjernswärd, J. ; Löwhagen, T.</creator><creatorcontrib>Jereb, B. ; Stjernswärd, J. ; Löwhagen, T.</creatorcontrib><description>In 79 cases of histologically verified anaplastic giant‐cell carcinoma, symptoms, treatment, and prognosis were documented. Seventy‐eight patients are dead, the mean survival time being 2.5 months. One patient is cured. It was concluded that surgery and/or radiotherapy alone are not sufficient. The results from an additional 8 patients also treated with methotexate indicate a positive therapeutic effect, the mean survival time being 9.4 months. Disappearance of recurrent tumor or pulmonary metastases was noted in 2 patients.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(197505)35:5<1293::AID-CNCR2820350504>3.0.CO;2-W</identifier><identifier>PMID: 1122480</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Aged ; Female ; Giant Cell Tumors - drug therapy ; Giant Cell Tumors - radiotherapy ; Giant Cell Tumors - surgery ; Giant Cell Tumors - therapy ; Humans ; Male ; Methotrexate - therapeutic use ; Middle Aged ; Prognosis ; Thyroid Neoplasms - drug therapy ; Thyroid Neoplasms - radiotherapy ; Thyroid Neoplasms - surgery ; Thyroid Neoplasms - therapy ; Time Factors</subject><ispartof>Cancer, 1975-05, Vol.35 (5), p.1293-1295</ispartof><rights>Copyright © 1975 American Cancer Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1122480$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jereb, B.</creatorcontrib><creatorcontrib>Stjernswärd, J.</creatorcontrib><creatorcontrib>Löwhagen, T.</creatorcontrib><title>Anaplastic giant‐cell carcinoma of the thyroid. A study of treatment and prognosis</title><title>Cancer</title><addtitle>Cancer</addtitle><description>In 79 cases of histologically verified anaplastic giant‐cell carcinoma, symptoms, treatment, and prognosis were documented. Seventy‐eight patients are dead, the mean survival time being 2.5 months. One patient is cured. It was concluded that surgery and/or radiotherapy alone are not sufficient. The results from an additional 8 patients also treated with methotexate indicate a positive therapeutic effect, the mean survival time being 9.4 months. Disappearance of recurrent tumor or pulmonary metastases was noted in 2 patients.</description><subject>Adult</subject><subject>Aged</subject><subject>Female</subject><subject>Giant Cell Tumors - drug therapy</subject><subject>Giant Cell Tumors - radiotherapy</subject><subject>Giant Cell Tumors - surgery</subject><subject>Giant Cell Tumors - therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Methotrexate - therapeutic use</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Thyroid Neoplasms - drug therapy</subject><subject>Thyroid Neoplasms - radiotherapy</subject><subject>Thyroid Neoplasms - surgery</subject><subject>Thyroid Neoplasms - therapy</subject><subject>Time Factors</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1975</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkd9q2zAUh0VpabOuj1Dw1egunB1JViRlY2C8rg2EBkagvTsostS6-E9mOYzc7RH6jHuS2ktoaS-EkL6jI-n3EZJSGFMA9oWCljHQhF1QLQWIz1xMxTfKNJ9O09mPOLvJfjHFgPcMku98DONs8ZXFtwdk9HL2kIwAQMUi4Xcn5EMIj_1SMsGPyTGljCUKRmSZ1mZdmtAVNrovTN39-_tkXVlG1rS2qJvKRI2PugfXj23bFPk4SqPQbfLt__3Wma5ydReZOo_WbXNfN6EIH8mRN2VwZ_v5lCx_Xi6z63i-uJpl6TxeM62TWEP_O7miwjJjLAM5ybVKJk77CUjhvZ6smPRKSpdobnMpLXijEu_5SlAr-Sn5tGvbX_x740KHVRGGx5vaNZuAikmlleR94fm-cLOqXI7rtqhMu8V9Cj3Pd_xPUbrtKwYcbOCQKA6J4s4GcoECBxvYy8C3MpAjYLZAhrfvCH8GCGWETA</recordid><startdate>197505</startdate><enddate>197505</enddate><creator>Jereb, B.</creator><creator>Stjernswärd, J.</creator><creator>Löwhagen, T.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>197505</creationdate><title>Anaplastic giant‐cell carcinoma of the thyroid. A study of treatment and prognosis</title><author>Jereb, B. ; Stjernswärd, J. ; Löwhagen, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2994-901977b15c2aac2076d9846e9f6075ff96b27f877e493cd77c0fa84ff3b51c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1975</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Female</topic><topic>Giant Cell Tumors - drug therapy</topic><topic>Giant Cell Tumors - radiotherapy</topic><topic>Giant Cell Tumors - surgery</topic><topic>Giant Cell Tumors - therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Methotrexate - therapeutic use</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Thyroid Neoplasms - drug therapy</topic><topic>Thyroid Neoplasms - radiotherapy</topic><topic>Thyroid Neoplasms - surgery</topic><topic>Thyroid Neoplasms - therapy</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jereb, B.</creatorcontrib><creatorcontrib>Stjernswärd, J.</creatorcontrib><creatorcontrib>Löwhagen, T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jereb, B.</au><au>Stjernswärd, J.</au><au>Löwhagen, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anaplastic giant‐cell carcinoma of the thyroid. A study of treatment and prognosis</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1975-05</date><risdate>1975</risdate><volume>35</volume><issue>5</issue><spage>1293</spage><epage>1295</epage><pages>1293-1295</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>In 79 cases of histologically verified anaplastic giant‐cell carcinoma, symptoms, treatment, and prognosis were documented. Seventy‐eight patients are dead, the mean survival time being 2.5 months. One patient is cured. It was concluded that surgery and/or radiotherapy alone are not sufficient. The results from an additional 8 patients also treated with methotexate indicate a positive therapeutic effect, the mean survival time being 9.4 months. Disappearance of recurrent tumor or pulmonary metastases was noted in 2 patients.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>1122480</pmid><doi>10.1002/1097-0142(197505)35:5<1293::AID-CNCR2820350504>3.0.CO;2-W</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 1975-05, Vol.35 (5), p.1293-1295 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_82789873 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adult Aged Female Giant Cell Tumors - drug therapy Giant Cell Tumors - radiotherapy Giant Cell Tumors - surgery Giant Cell Tumors - therapy Humans Male Methotrexate - therapeutic use Middle Aged Prognosis Thyroid Neoplasms - drug therapy Thyroid Neoplasms - radiotherapy Thyroid Neoplasms - surgery Thyroid Neoplasms - therapy Time Factors |
| title | Anaplastic giant‐cell carcinoma of the thyroid. A study of treatment and prognosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T08%3A37%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anaplastic%20giant%E2%80%90cell%20carcinoma%20of%20the%20thyroid.%20A%20study%20of%20treatment%20and%20prognosis&rft.jtitle=Cancer&rft.au=Jereb,%20B.&rft.date=1975-05&rft.volume=35&rft.issue=5&rft.spage=1293&rft.epage=1295&rft.pages=1293-1295&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/1097-0142(197505)35:5%3C1293::AID-CNCR2820350504%3E3.0.CO;2-W&rft_dat=%3Cproquest_pubme%3E82789873%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=82789873&rft_id=info:pmid/1122480&rfr_iscdi=true |